New Daily Weight-Loss Pill Shows Promising Results in…

New Daily Weight-Loss Pill Shows Promising Results in Diabetes Trial Published: June 2026 | Category: Diabetes, Obesity, Medications | TALMedora Editorial Desk Weight-loss medications have transformed diabetes and obesity treatment in recent years. But most of the best-known options, including Ozempic and Wegovy, require injections. Now, a new experimental pill could offer patients another option. Researchers report that AstraZeneca's oral GLP-1 medication, elecoglipron, helped people with type 2 diabetes lower blood sugar levels and lose significant weight in a recent clinical trial. The findings add to growing evidence that the future of diabetes and obesity treatment may not always involve injections. What Did the Study Find? The phase 2 clinical trial included more than 400 adults living with type 2 diabetes across multiple countries. After 26 weeks of treatment: ✅ Nearly 90% of participants reached recommended blood sugar targets. ✅ Participants lost an average of 10.5% of their body weight. ✅ More than 70% achieved at least 5% weight loss. Researchers also reported that the medication's side effects were generally similar to those seen with other GLP-1 treatments currently on the